Literature DB >> 8199793

The nature of depression among older people in inner London, and the contact with primary care.

M R Blanchard1, A Waterreus, A H Mann.   

Abstract

Ninety-six people of pensionable age from an inner-London electoral ward who had been identified by short-CARE screening as having 'probable pervasive depression' were interviewed further to ascertain their GMS-AGECAT and self-CARE status, comorbid features, and current primary-care psychiatric management. Estimated incidence rates of 30.8 per 1000 per year for 'probable pervasive depression' and 15.4 per 1000 per year for GMS diagnostic depression were calculated using results from a short-CARE screen in 1988. Among GMS diagnostic depression cases, anxiety was the major psychiatric comorbid feature (95%) and organic features were uncommon (8.4%). Of 66 self-CARE cases, 48 (73%) were also GMS-AGECAT cases; of 24 self-CARE non-cases, 15 (62.5%) were not GMS-AGECAT cases. Among subjects who had 'probable pervasive depression', 38% said that they had declared their symptoms to their general practitioner. Only 14% of subjects were prescribed antidepressants; 24% were prescribed hypnotics. Half the GMS-AGECAT-case subjects who stated that they had declared to their general practitioner were on specific therapy. Screening for depression and health education aimed at increasing psychological declaration are seen as ways forward in the management of this depression.

Entities:  

Mesh:

Year:  1994        PMID: 8199793     DOI: 10.1192/bjp.164.3.396

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

1.  Influence of symptoms of anxiety on treatment of depression in later life in primary care: questionnaire survey.

Authors:  M Kirby; A Denihan; I Bruce; A Radic; D Coakley; B A Lawlor
Journal:  BMJ       Date:  1999-02-27

2.  Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.

Authors:  Philip S Wang; Amanda R Patrick; Colin Dormuth; Malcolm Maclure; Jerry Avorn; Claire F Canning; Sebastian Schneeweiss
Journal:  J Ment Health Policy Econ       Date:  2010-03

Review 3.  Anxiety disorders in late life.

Authors:  A J Flint
Journal:  Can Fam Physician       Date:  1999-11       Impact factor: 3.275

4.  Randomised controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home.

Authors:  S Banerjee; K Shamash; A J Macdonald; A H Mann
Journal:  BMJ       Date:  1996-10-26

5.  Older patients' aversion to antidepressants. A qualitative study.

Authors:  Jane L Givens; Catherine J Datto; Katy Ruckdeschel; Kathryn Knott; Cynthia Zubritsky; David W Oslin; Soumya Nyshadham; Poornima Vanguri; Frances K Barg
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

Review 6.  The epidemiology of functional psychoses of late onset.

Authors:  A S Henderson; D W Kay
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 7.  The epidemiology of depressive states in the elderly: implications for recognition, intervention and prevention.

Authors:  A F Jorm
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

8.  The impact of cost sharing on antidepressant use among older adults in British Columbia.

Authors:  Philip S Wang; Amanda R Patrick; Colin R Dormuth; Jerry Avorn; Malcolm Maclure; Claire F Canning; Sebastian Schneeweiss
Journal:  Psychiatr Serv       Date:  2008-04       Impact factor: 3.084

9.  [Quo vadis geropsychiatry? Perspectives for a new "state of the art"].

Authors:  Günter Klug; Gerhard Hermann; Brigitte Fuchs-Nieder
Journal:  Wien Med Wochenschr       Date:  2006-02

10.  Brief Screening for Four Mental Illnesses of the Elderly in Community Mental Health Services: the BS4MI-Elderly.

Authors:  Kyeong Seon Yun; Bong-Goon Moon; Miae Park; Seong-Ju Kim; Yunmi Shin; Sun Mi Cho; Jai Sung Noh; Ki-Young Lim; Young-Ki Chung; Sang Joon Son; Hyun Woong Roh; Chang Hyung Hong
Journal:  Psychiatry Investig       Date:  2020-05-08       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.